Clinical Trial Update: A Study of ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver [Phase 1]

View source ↗

Summary

Completed Phase 1 study evaluating ThermoDox in combination with radiofrequency ablation for primary and metastatic liver tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Neoplasms

Drugs mentioned

• ThermoDox (doxorubicin liposome)

Snippet

Sponsor: Imunon | Conditions: Hepatocellular Carcinoma, Liver Neoplasms | Phase 1 | Status: COMPLETED